J. Tabira

Efficacy and Safety of Bococizumab (RN316/PF-04950615), a Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9, in Hypercholesterolemic Japanese Subjects Receiving a Stable Dose of Atorvastatin or Treatment-Naive　- Results From a Randomized, Placebo-Controlled, Dose-Ranging Stud

K. Yokote, T. Teramoto, N. Matsuoka, 2017, Circulation journal : official journal of the Japanese Circulation Society.

Tofacitinib induction and maintenance therapy in East Asian patients with active ulcerative colitis: subgroup analyses from three phase 3 multinational studies

T. Hibi, Mamoru Watanabe, H. J. Kim, 2018, Intestinal research.

Tofacitinib as Induction and Maintenance Therapy in Japanese Patients with Active Ulcerative Colitis

T. Matsui, T. Hibi, Mamoru Watanabe, 2019, Inflammatory Intestinal Diseases.

Safety and efficacy of long‐term tofacitinib treatment in East Asian patients with ulcerative colitis in OCTAVE Open

T. Hibi, B. Ye, T. Hisamatsu, 2022, Journal of gastroenterology and hepatology.

Corrigendum: Tofacitinib induction and maintenance therapy in East Asian patients with active ulcerative colitis: subgroup analyses from three phase 3 multinational studies

T. Hibi, Mamoru Watanabe, D. Han, 2018, Intestinal research.

Comparison of gastroduodenal ulcer incidence in healthy Japanese subjects taking celecoxib or loxoprofen evaluated by endoscopy: a placebo‐controlled, double‐blind 2‐week study

C. Sakamoto, T. Kawai, T. Sugioka, 2013, Alimentary pharmacology & therapeutics.